Document Detail


Clinical management of clozapine patients in relation to efficacy and side-effects.
MedLine Citation:
PMID:  1358128     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Medical charts of 480 schizophrenic in-patients (581 treatments) were analysed to evaluate the efficacy and side-effects of clozapine. Clozapine treatment lasted for mean 49 (s.d. 38) days. Of the sample, 11.0% showed worsening or no change, 31.5% slight improvement, 53.0% marked improvement and 4.5% almost total reduction of symptoms. At least one major side-effect occurred in 68.0% of patients. A combination of clozapine with classical neuroleptics, antidepressants, benzodiazepines or lithium is tolerated by most patients, but increases the incidence of some side-effects. Clozapine treatment had to be discontinued because of severe side-effects in 8.6% of patients. In 81 schizophrenic out-patients, clozapine significantly reduced the days of in-patient treatment and number of hospital readmissions. Two patients developed leucopenia but had no complications after clozapine withdrawal. This study indicates a satisfactory benefit/risk ratio and compliance in most of the patients.
Authors:
D Naber; R Holzbach; C Perro; H Hippius
Related Documents :
10202608 - 3h-spiperone binding to lymphocytes in neuroleptic-naive-schizophrenia and the effect o...
2885368 - The evaluation of an ultrasound detector (ud) in the measurement of oro-facial dyskinesia.
11205348 - Neural network analysis of the pattern of functional connectivity between cerebral area...
18452258 - Toxocara seroprevalence in schizophrenic patients in turkey.
3115628 - Subacute spongiform encephalopathy with periodic paroxysmal activities: clinical evolut...
3708878 - Naloxone provokes catecholamine release in phaeochromocytomas and paragangliomas.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  The British journal of psychiatry. Supplement     Volume:  -     ISSN:  0960-5371     ISO Abbreviation:  Br J Psychiatry Suppl     Publication Date:  1992 May 
Date Detail:
Created Date:  1992-12-02     Completed Date:  1992-12-02     Revised Date:  2008-02-22    
Medline Journal Info:
Nlm Unique ID:  9001294     Medline TA:  Br J Psychiatry Suppl     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  54-9     Citation Subset:  IM    
Affiliation:
Psychiatric Hospital, University of Munich, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Antipsychotic Agents / therapeutic use
Clozapine / administration & dosage,  adverse effects,  therapeutic use*
Drug Therapy, Combination
Female
Hospitalization
Humans
Male
Middle Aged
Patient Compliance
Schizophrenia / diagnosis,  drug therapy*
Schizophrenic Psychology
Chemical
Reg. No./Substance:
0/Antipsychotic Agents; 5786-21-0/Clozapine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  General pharmacology of clozapine.
Next Document:  Clinical aspects and distribution of immunologically active cells in the nasal mucosa of patients wi...